Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy
B. Alpen et al., Molecular diagnostics in low-grade gastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type after Helicobacter pylori eradication therapy, CLIN LYMPHO, 2(2), 2001, pp. 103-108
The primary gastric lymphomas are extranodal non-Hodgkin's lymphomas that l
ikely originate from the mucosa-associated lymphoid tissue (MALT). Data sug
gest that chronic infection with Helicobacter pylori (H pylori) is signific
antly associated with the pathogenesis of low-grade gastric MALT lymphomas.
This is in keeping with the observation that many patients with early low-
grade MALT lymphomas have complete remissions after H pylori eradication th
erapy. However, the stability of these remissions remains unclear and relap
ses have been reported. It can be difficult to distinguish between early ma
lignant and benign disorders of the gastric mucosa. A polymerase chain reac
tion (PCR) assay can detect rearrangements of the variable region of immuno
globulin heavy chains. This assay can be used to distinguish the clonality
of B lymphocytes and has been investigated as a test for differential diagn
osis of MALT lymphomas. Monoclonality is observed in the majority of MALT-l
ymphoma samples at diagnosis but has been found in gastritis samples as wel
l. Whether the presence of monoclonal B cells is associated with the risk o
f lymphoma progression remains unclear. As many as 50% of patients who have
complete histologic remissions of MALT lymphoma after H pylori eradication
therapy have persisting monoclonal bands in follow-up PCR monitoring. Alth
ough it is unclear as to whether monoclonality indicates the presence of mi
nimal residual disease, patients who have persistent monoclonal bands durin
g follow-up should be considered at risk for relapse. The PCR assay for rea
rrangements of the variable region of the immunoglobulin heavy-chain gene a
ppears to be of low value in the diagnosis of B-cell malignancies but could
provide a useful tool in the follow-up of patients who achieve remissions
after H pytori eradication.